Skip to main content
OpenTrials
Completed

NCT Number: NCT04584801

SLP Model Development in the Diagnosis of COPD Patients

This is an observational, comparative, multicentre study to develop a model for the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Buckinghamshire Healthcare NHS Trust - Stoke Mandeville Hospital, Aylesbury, United Kingdom

Loading trial locations.

About this study

This study will generate data to characterise the tidal breathing patterns and parameters with Thora-3Di™ against spirometry FEV1/FVC and %predicted. Subjects will have a Part A visit (Development Phase) to develop algorithms for COPD diagnosis. At Part A visit, subjects will have two 5-minute SLP measurements (Pre and Post bronchodilator). The SLP measurement should be performed prior to standard lung function tests with minimal impact on clinical time and no change to hospital attendance. Also, subjects will be asked to report concomitant medications and adverse events and fill in COPD assessment test (CAT™).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any adult (≥18 years old) who has been diagnosed with COPD guide GOLD criteria (FEV1/FVC ratio post bronchodilator <0.70)
  • Healthy Smokers (≥35 years old, current or ex-smoker with a history of ≥10 pack years (20 cigarettes smoked per day for 10 year))

Exclusion criteria

  • Be unable to sit in an upright position for required period
  • Have had deteriorated COPD symptoms since the last spirometry unless willing to undergo spirometry testing
  • Have significant co-morbidities (i.e. Chest work or spinal deformity, OSA, AHI >30 secs
  • Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participants' ability to participate in the study
  • Height > 194 cm
  • BMI >40
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study
  • Be unable to consent or comply with the study protocol

Treatment and study plan

Structured Light Plethysmography

Device

Development Phase (Original Part A): Participants will have two 5-minute SLP measurements (Pre and Post bronchodilator).

Participants will also undergo standard of care spirometry assessment

Other names: Thora-3Di™

Primary outcomes

  1. To develop a machine learning model to use SLP data in patients diagnosed with COPD or healthy smokers to predict historical spirometry results (within 6 months) or prospective spirometry results, and classify subjects according to COPD/non-COPD.

    Time frame: 2 years

    The proportion of points falling between the upper and lower 95% CIs of the Bland-Altman plot of the average of FEV1/FVC spirometer values and the output from the model using the SLP parameters against the difference between the spirometer values and their SLP parameter model counterparts.

Secondary outcomes

  1. To evaluate the safety of the Thora-3Di™

    Time frame: 2 years

    Incidence of adverse events while the SLP techniques are carried out.

Sponsors and collaborators

Lead sponsor

Pneumacare Ltd

Industry

Registry information

Official study title

A Comparative, Multi Centre Study, to Develop a Model for Structured Light Plethysmography Against Standard of Care in the Diagnosis of Chronic Obstructive Pulmonary Disease for Patients Who Plan to Undergo Spirometry Testing

Acronym: SLPCOPD

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Oct 14, 2020
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.